Medical device maker Medtronic is looking at options to modify its global manufacturing footprint as part of efforts to ...

Medtronic (MDT) is reportedly looking at adjusting its global manufacturing footprint amid heightened concerns that the U.S.

But thermodynamics are completely different in an isochoric system, where volume remains constant and pressure changes.” In ...

Medtronic said Monday the U.S. Food and Drug Administration has approved an adaptive brain-stimulation device as a treatment ...

After decades of development and trials, Medtronic has secured U.S. Food and Drug Administration approval for adaptive ...

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including The Charles Schwab Corp. (SCHW), ...

The biggest technical challenge for adaptive deep brain stimulation (aDBS) is how small brain signals are, Medtronic's Scott ...

The latest health news reveals Medtronic's strategic response to U.S. tariffs, WHO's concerns on West Bank violence, mystery ...

In a welcome move, Medtronic stock saw its Relative Strength Rating improve from 67 to 73 on Tuesday. Please watch the video ...

The FDA has approved Medtronic's Brainsense Adaptive deep brain stimulation for patients with Parkinson's disease. The technology is designed to adjust therapy in real time based on a patient's brain ...

The neurovascular market, estimated at $4.2bn in 2024 by GlobalData, is becoming increasingly specialised and competitive.

Medtronic's agnostic approach to global challenges, including tariffs and AI, ensures success and innovation in healthcare ...